HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
Franklin India Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

Franklin India Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

Franklin India Focused Equity Fund - Direct (G)

7.58%

stock2

Nippon India Pharma Fund - Direct (G)

17.52%

Graph not available
Graph not available

About Fund

Citibank N.A. Deutsche Bank

Franklin Templeton Asset Management (India) Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

11396.38

1.46

115.9471

January 1, 2013

0

Very High Risk

5000

8080.97

1.12

552.0188

January 1, 2013

1

27.43 %

17.75 %

7.58 %

23.81 %

21.22 %

17.52 %

Ajay Argal

B. Tech (IIT Mumbai), PGDM (IIM Banglore)

Over 12 years experience. Prior to joining BSLAMC, he has worked with UTI AMC and had handled various aspects of the investments Function including managing offshore funds, equity funds, balanced funds, equity research and equity dealing

K N Siva Subramanian

B.E from REC Jaipur, PGDM from IIM-C

Since - Feb 2005. Prior to this he was Industrial Finance Office with IDBI from 1988-1993.

R Janakiraman

B.E., PGDBM.

Prior to joining Franklin Templeton AMC, he had worked as investment manager for Indian Syntans Invt Pvt. Ltd., with Citicorp information Tech Ltd. and with UTI Securities Exchange Ltd.

Roshi Jain

Post Graduate Diploma in Management.CFA., ACA., CFA, PGDM, ACA

She is responsible for investment in foreign securities research (Since May 2005), identifying investment opportunities in capital goods, retail, textiles & transportation sector. Prior Goldman sachs, london (2004 - 2005) Responsible for equity Researched European building material stocks. - Goldman sachs, Singapore / HK (2002 - 2004). Responsible for equity research, researched Asian retail stocks. Wipro ltd. (1999 - 2000). Responsible for internal audit, Internal audit of processes & transactions. - S. R. Batliboi & Co. (1999). Responsible for statutory audit of corporate.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing Franklin India Focused Equity Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both Franklin India Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing Franklin India Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between Franklin India Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare Franklin India Focused Equity Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions